MediNice SA(PL:ICE)
zł 45.40-3.50 (-10.10%)
PL:ICE
MediNice SA financials statements
zł 45.40
At close:-3.50 (-10.10%)
MediNice SA (ICE) Ratios
0 Followers
MediNice SA Ratios
PL:ICE's free cash flow for Q2 2026 was zł-1.23M. For the 2026 fiscal year, PL:ICE's free cash flow was increased by zł0.00 and operating cash flow was zł-1.23M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.87 | 4.00 | 9.47 | 21.66 | 28.35 |
| Quick Ratio | 6.87 | 4.00 | 9.47 | 21.66 | 28.35 |
| Cash Ratio | 6.63 | 3.70 | 8.93 | 20.91 | 27.50 |
| Solvency Ratio | -1.40 | 6.76 | -1.11 | -0.98 | -0.30 |
| Operating Cash Flow Ratio | -3.86 | -1.48 | -2.98 | -2.75 | -1.45 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -20.88 | 0.00 | -13.53 | -4.34 |
| Net Current Asset Value | zł 5.34M | zł 4.25M | zł 6.62M | zł 17.17M | zł 24.32M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.05 | 1.07 | 1.13 | 1.13 | 1.21 |
| Debt Service Coverage Ratio | -153.31 | 166.78 | -76.24 | -18.48 | -5.90 |
| Interest Coverage Ratio | -161.36 | 716.04 | -93.21 | -83.32 | -81.40 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.05 | 0.06 | 0.09 | 0.10 | 0.14 |
| Net Debt to EBITDA | 1.43 | -0.23 | 2.08 | 4.44 | 12.29 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -13.83% | 33.33% | 54.88% | 74.31% |
| EBIT Margin | 0.00% | 20002.13% | -2227.11% | -1977.64% | -978.13% |
| EBITDA Margin | 0.00% | 20124.47% | -2100.89% | -1884.55% | -880.21% |
| Operating Profit Margin | 0.00% | 19805.32% | -2568.44% | -2032.11% | -1215.28% |
| Pretax Profit Margin | 0.00% | 19974.47% | -2254.22% | -2002.03% | -998.61% |
| Net Profit Margin | 0.00% | 19987.77% | -2254.22% | -2002.03% | -1001.04% |
| Continuous Operations Profit Margin | 0.00% | 19987.77% | -2254.22% | -2002.03% | -1002.08% |
| Net Income Per EBT | 99.79% | 100.07% | 100.00% | 100.00% | 100.24% |
| EBT Per EBIT | 99.41% | 100.85% | 87.77% | 98.52% | 82.17% |
| Return on Assets (ROA) | -7.25% | 43.39% | -13.53% | -11.75% | -5.86% |
| Return on Equity (ROE) | -7.63% | 46.39% | -15.29% | -13.27% | -7.10% |
| Return on Capital Employed (ROCE) | -7.42% | 44.25% | -15.90% | -12.23% | -7.29% |
| Return on Invested Capital (ROIC) | -7.39% | 44.07% | -15.83% | -12.14% | -7.22% |
| Return on Tangible Assets | -62.58% | 351.94% | -28.26% | -17.36% | -7.45% |
| Earnings Yield | -4.68% | 72.10% | -8.09% | -5.66% | -2.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.27 | 0.39 | 3.00 | 0.47 |
| Payables Turnover | 0.53 | 0.22 | 0.20 | 0.20 | 0.37 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.29 | 0.27 | 0.30 | 0.54 |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Working Capital Turnover Ratio | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 |
| Cash Conversion Cycle | -686.02 | -312.22 | -884.11 | -1693.47 | -212.13 |
| Days of Sales Outstanding | 0.00 | 1360.98 | 945.76 | 121.67 | 774.36 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 686.02 | 1673.20 | 1829.87 | 1815.14 | 986.49 |
| Operating Cycle | 0.00 | 1360.98 | 945.76 | 121.67 | 774.36 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.66 | -0.55 | -0.54 | -0.45 | -0.29 |
| Free Cash Flow Per Share | -1.38 | -0.55 | -1.55 | -1.01 | -1.05 |
| Dividend Paid and CapEx Coverage Ratio | -0.92 | -1218.00 | -0.53 | -0.79 | -0.39 |
| Capital Expenditure Coverage Ratio | -0.92 | -1218.00 | -0.53 | -0.79 | -0.39 |
| Operating Cash Flow Coverage Ratio | -15.30 | -10.56 | -6.81 | -4.79 | -2.20 |
| Operating Cash Flow to Sales Ratio | 0.00 | -19.44 | -15.32 | -11.33 | -5.84 |
| Free Cash Flow Yield | -8.12% | -7.02% | -15.83% | -7.25% | -5.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -21.25 | 1.39 | -12.36 | -17.66 | -40.78 |
| Price-to-Sales (P/S) Ratio | 0.00 | 277.23 | 278.59 | 353.48 | 408.27 |
| Price-to-Book (P/B) Ratio | 1.63 | 0.64 | 1.89 | 2.34 | 2.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -12.32 | -14.25 | -6.32 | -13.79 | -19.48 |
| Price-to-Operating Cash Flow Ratio | -25.72 | -14.26 | -18.18 | -31.19 | -69.91 |
| Price-to-Earnings Growth (PEG) Ratio | 0.19 | -0.00 | 0.00 | -0.30 | 3.81 |
| Enterprise Value Multiple | -20.82 | 1.15 | -11.18 | -14.31 | -34.09 |
| Enterprise Value | 134.33M | 43.34M | 52.87M | 66.35M | 86.42M |
| EV to EBITDA | -20.82 | 1.15 | -11.18 | -14.31 | -34.09 |
| EV to Sales | 0.00 | 230.55 | 234.96 | 269.72 | 300.08 |
| EV to Free Cash Flow | -11.53 | -11.85 | -5.33 | -10.53 | -14.32 |
| EV to Operating Cash Flow | -24.06 | -11.86 | -15.34 | -23.80 | -51.38 |
| Tangible Book Value Per Share | 0.73 | 0.76 | 2.13 | 3.78 | 5.22 |
| Shareholders’ Equity Per Share | 10.43 | 12.12 | 5.19 | 5.95 | 7.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 | -0.06 | -0.00 |
| Revenue Per Share | 0.00 | 0.03 | 0.04 | 0.04 | 0.05 |
| Net Income Per Share | -0.80 | 5.62 | -0.79 | -0.79 | -0.50 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.00 | 1.01 | 1.01 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.40 | 0.33 | 0.35 | 0.28 |
| SG&A to Revenue | 0.00 | 1.93 | 0.00 | 0.00 | 4.72 |
| Stock-Based Compensation to Revenue | 0.00 | 3.55 | 4.86 | 6.23 | 2.77 |
| Income Quality | 0.83 | -0.10 | 0.68 | 0.57 | 0.59 |
Currency in PLN
